Appendix B: Panel Roster and Financial Disclosures
Section Review Group
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Lydia Aoun Barakat | Yale University School of Medicine | None | N/A |
| Rodrigo Burgos | University of Illinois Chicago College of Pharmacy | OptumRx | Consultant |
Merck Janssen Vaccines & Prevention Moderna | Research Support (paid to institution) | ||
| Thomas Campbell* | University of Colorado School of Medicine | None | N/A |
| Catherine Decker | Walter Reed National Military Medical Center | None | N/A |
| Ellen Kitchell | The University of Texas Southwestern Medical School | None | N/A |
| Susana Lazarte | The University of Texas Southwestern Medical Center | Gilead Sciences | Research Support (paid to institution) |
| Paul Pham | The Johns Hopkins University School of Medicine; Westview Urgent Care Medi Center | Novo Nordisk | Stockholder |
| Gregory Robbins | Massachusetts General Hospital | Leonard-Meron Biosciences Seed Health/LUCA Biologics Teradyne | Consultant |
Emergent BioSolutions Pfizer | Research Support | ||
| Anandi Sheth | Emory University School of Medicine | None | N/A |
| William Short | Perelman School of Medicine at the University of Pennsylvania | ViiV Healthcare | Advisory Board |
| Gilead Sciences | Research Support | ||
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (20.21 KB)
- Full Guideline PDF (6.08 MB)
- Tables Only PDF (918.31 KB)